DUSP1 and urinary bladder carcinoma: Thus, LINC00702-activated DUSP1 suppresses bladder cancer cell proliferation and inhibits the secretion of inflammatory cytokines IL-4, IL-10, and TNF-α M2-OAM in bladder cancer.